Endocrine oncology

Clinical Impact of Genetic Alterations in Pediatric Papillary Thyroid Carcinoma: A Next-Generation Sequencing Study from Argentina

Horm Res PaediatrPublished Retrospective descriptive study

Authors' conclusion

Interestingly, in our PTC cohort, the NGS panel was highly specific to detect molecular alterations. Fusions were more frequent at a younger age and in the ATA-2015 high-recurrence-risk group; however, it was not a determining factor to predict PTC outcome. Finally, detection of pathological germline mutations in genes involved in HTPS was useful for genetic counseling.

Study context

Population
Consecutive pediatric patients with papillary thyroid cancer (PTC) at a single center in Argentina, with a DNA-based next-generation sequencing (NGS) panel; all treated with total thyroidectomy and radioiodine
Participants
63 patients
Exposure
Low risk vs Intermediate risk vs High risk
  • Low riskn = 10
  • Intermediate riskn = 13
  • High riskn = 40
Outcome
Pathogenic somatic variants on NGS panel
Methodological detailssingle-centre, consecutive patients
  • Single-centre
  • Consecutive patients

Main finding

As reported in the abstract

Pathogenic somatic variant detected

70%

44/63

Most frequent alteration: RET fusions

20%

Observational data: associations, not effects.

Further findings

Fusions by age

Fusions more frequent in younger patients (median age 11.45 vs. 13.7 years)
P = 0.048

Fusions by histology and recurrence risk

Fusions more frequent in diffuse sclerosing subtype
P = 0.01
Fusions more frequent in high-recurrence risk group
P < 0.014

Persistent disease (PD) by risk group · last follow-up

Risk of PD higher in high-risk group (OR)
9.2

Molecular findings by treatment response · last follow-up

PD (n=19): fusions 12 (64%), point variants 7 (36%); statistically significant
P < 0.01
Excellent response (n=25): fusions 12 (48%), point variants 13 (52%); no statistically significant difference

Pathological germline mutations in hereditary tumor predisposition syndrome (HTPS) genes

Germline mutations
5/63 (8%)
DICER1
2
PTEN
1
MSH6
2

Original publication

Clinical Impact of Genetic Alterations in Pediatric Papillary Thyroid Carcinoma: A Next-Generation Sequencing Study from Argentina. Horm Res Paediatr. Published 7 November 2025. doi:10.1159/000549332

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.